The Ramazzini Institute
for Occupational and Environmental Health Research   

Who Are We?

• Unfinished Agenda: The Congress of the United States and the White House left a lot on the table for the new President and Congress, from genetic discrimination to the regulation of research practices. Deregulation of environmental controls in the community and the workplace - and the role of genetic information in risk assessment and management - will be key concerns.
• The new directions in the NIH Office of Research Subject Protection.
• What happens to workers who “flunk” genetic and other tests indicating “susceptibility” pr “sensitivity” to the toxic agents they work with?
• Some “heavy” reading from scientists and philosophers with something important to say about the prospects for ethical gene research and therapy.! Reviews of writings by evolutionist Susan Oyama, philosophers Gewirth, Gert and Grisez, and a literature review by William Rom.on cancer and genes.
• Should we worry about laboratory animals in pain? Even Guppies? What Flipper did for animal rights and the human condition.
• Are they really patenting my genes? The economics of gene therapy and the new drugs and treatments may really hinge on what we mean by a “gene.”
• Israel’s new Selikoff Center is taking shape.
• Employee Assistance Programs: An update.
• The European Environmental Agency’s approach to regulation: a critique.
• The ethics and effectiveness of market approaches to environmental regulation: still more questions.